Select Publications
Journal articles
2024, 'Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era.', Intern Med J, http://dx.doi.org/10.1111/imj.16445
,2024, 'International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.', J Clin Oncol, 42, pp. 2271 - 2280, http://dx.doi.org/10.1200/JCO.23.01655
,2024, 'Donor Types and Outcomes of Transplantation in Myelofibrosis: A CIBMTR Study.', Blood Adv, http://dx.doi.org/10.1182/bloodadvances.2024013451
,2024, 'Sequential high‐dose methotrexate and cytarabine administration improves outcomes in real‐world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance', eJHaem, http://dx.doi.org/10.1002/jha2.951
,2024, 'Variation in immunoglobulin use and impact on survival in myeloma', eJHaem, http://dx.doi.org/10.1002/jha2.938
,2024, 'International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update', Bone Marrow Transplantation, 59, pp. 717 - 741, http://dx.doi.org/10.1038/s41409-023-02190-2
,2024, 'Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance', Internal Medicine Journal, 54, pp. 1017 - 1030, http://dx.doi.org/10.1111/imj.16390
,2024, 'Poor reporting limited consideration of EDI in the Australian guidelines for the clinical care of people with COVID-19', Journal of Clinical Epidemiology, 170, http://dx.doi.org/10.1016/j.jclinepi.2024.111361
,2024, 'International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update', Transplantation and Cellular Therapy, 30, pp. 349 - 385, http://dx.doi.org/10.1016/j.jtct.2023.12.001
,2024, 'Pregnancy-associated gynecological cancer in New South Wales, Australia 1994–2013: A population-based historical cohort study', Acta Obstetricia et Gynecologica Scandinavica, 103, pp. 729 - 739, http://dx.doi.org/10.1111/aogs.14530
,2024, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies', Transplantation and Cellular Therapy, 30, pp. 334.e1 - 334.e7, http://dx.doi.org/10.1016/j.jtct.2023.11.018
,2024, 'CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study', Blood, 143, pp. 673 - 684, http://dx.doi.org/10.1182/blood.2023021306
,2024, 'Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies', Internal Medicine Journal, 54, pp. 328 - 336, http://dx.doi.org/10.1111/imj.16303
,2024, 'Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease', Journal of Health Economics and Outcomes Research, pp. 23 - 31, http://dx.doi.org/10.36469/jheor.2024.92028
,2024, 'Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom', British Journal of Haematology, 204, pp. 548 - 554, http://dx.doi.org/10.1111/bjh.19179
,2024, 'The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma', Blood, 143, pp. 152 - 165, http://dx.doi.org/10.1182/blood.2023021348
,2024, 'Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies', Acta Haematologica, http://dx.doi.org/10.1159/000536548
,2024, 'Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease', Journal of Health Economics and Outcomes Research, 11, pp. 23 - 31, http://dx.doi.org/10.36469/001c.92028
,2024, 'Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group', The Lancet Haematology, 11, pp. e62 - e74, http://dx.doi.org/10.1016/S2352-3026(23)00305-8
,2024, 'Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study', British Journal of Haematology, http://dx.doi.org/10.1111/bjh.19407
,2024, 'Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project.', EJHaem, 5, pp. 325 - 332, http://dx.doi.org/10.1002/jha2.870
,2023, 'High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.', J Clin Oncol, 41, pp. 5376 - 5387, http://dx.doi.org/10.1200/JCO.23.00365
,2023, 'ANZTCT consensus position statement on ruxolitinib in steroid-refractory acute and chronic graft-versus-host disease', Internal Medicine Journal, 53, pp. 2319 - 2329, http://dx.doi.org/10.1111/imj.16255
,2023, 'Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT', The Lancet Haematology, 10, pp. e994 - e1005, http://dx.doi.org/10.1016/S2352-3026(23)00265-X
,2023, 'Pregnancy associated cancer, timing of birth and clinical decision making—a NSW data linkage study', BMC Pregnancy and Childbirth, 23, http://dx.doi.org/10.1186/s12884-023-05359-1
,2023, 'An International Multicenter Study of Primary Vitreoretinal Lymphoma from the Australasian Lymphoma Alliance and Collaborators', Blood, 142, pp. 3132 - 3132, http://dx.doi.org/10.1182/blood-2023-178431
,2023, 'Australasian Leukaemia & Lymphoma Group NHL35-Pacific: An Open Label Phase II Study of Pembrolizumab and Chemo-Immunotherapy As First-Line Therapy for Primary Mediastinal B-Cell Lymphoma - Trial in Progress', Blood, 142, pp. 3103 - 3103, http://dx.doi.org/10.1182/blood-2023-185160
,2023, 'Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study', Blood, 142, pp. 785 - 785, http://dx.doi.org/10.1182/blood-2023-179153
,2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', Blood, 142, pp. 3414 - 3414, http://dx.doi.org/10.1182/blood-2023-184319
,2023, 'Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study', Blood, 142, pp. 654 - 654, http://dx.doi.org/10.1182/blood-2023-172590
,2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0289907
,2023, 'Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study', The Lancet Haematology, 10, pp. e902 - e912, http://dx.doi.org/10.1016/S2352-3026(23)00207-7
,2023, 'Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis', Internal Medicine Journal, 53, pp. 1979 - 1986, http://dx.doi.org/10.1111/imj.16043
,2023, 'The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial', Nature Medicine, 29, pp. 2814 - 2824, http://dx.doi.org/10.1038/s41591-023-02593-0
,2023, 'An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy', Blood Advances, 7, pp. 5480 - 5484, http://dx.doi.org/10.1182/bloodadvances.2023010090
,2023, 'Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study', Blood Advances, 7, pp. 5554 - 5565, http://dx.doi.org/10.1182/bloodadvances.2023009840
,2023, 'Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance', Haematologica, 108, pp. 2444 - 2453, http://dx.doi.org/10.3324/haematol.2022.281375
,2023, 'PRESUMPTIVE RECURRENCE OF INTRAOCULAR LYMPHOMA DESPITE CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY', Retinal Cases and Brief Reports, 17, pp. 562 - 566, http://dx.doi.org/10.1097/ICB.0000000000001246
,2023, 'Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure', Bone Marrow Transplantation, 58, pp. 1024 - 1032, http://dx.doi.org/10.1038/s41409-023-02020-5
,2023, 'P1117: GLOFITAMAB PLUS R-CHOP OR POLATUZUMAB VEDOTIN-R-CHP IS DELIVERABLE AND YIELDS HIGH OVERALL RESPONSE IN PATIENTS <=65 YEARS OF AGE WITH HIGH-RISK DLBCL OR HGBL: INTERIM ANALYSIS OF THE COALITION STUDY', HemaSphere, 7, pp. e8608732 - e8608732, http://dx.doi.org/10.1097/01.hs9.0000971364.86087.32
,2023, 'P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY', HemaSphere, 7, pp. e24670ab - e24670ab, http://dx.doi.org/10.1097/01.hs9.0000971668.24670.ab
,2023, 'S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES', HemaSphere, 7, pp. e37234fb - e37234fb, http://dx.doi.org/10.1097/01.hs9.0000967956.37234.fb
,2023, 'American Society of Transplantation and Cellular Therapy International Affair Committee: Report of the Third Workshop on Global Perspective to Access to Transplantation at the 2022 Tandem Meeting', Transplantation and Cellular Therapy, 29, pp. 410 - 417, http://dx.doi.org/10.1016/j.jtct.2023.02.024
,2023, 'Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis', Haematologica, 108, pp. 1900 - 1908, http://dx.doi.org/10.3324/haematol.2022.281958
,2023, 'The need to accelerate COVID-19 education across medical schools', International journal of medical education, 14, pp. 75 - 76, http://dx.doi.org/10.5116/ijme.6488.1a6e
,2023, 'Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)', Bone Marrow Transplantation, 58, pp. 659 - 666, http://dx.doi.org/10.1038/s41409-023-01924-6
,2023, 'Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility', The Lancet Haematology, 10, pp. e458 - e467, http://dx.doi.org/10.1016/S2352-3026(23)00059-5
,2023, 'Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study', Transplantation and Cellular Therapy, 29, pp. 383.e1 - 383.e10, http://dx.doi.org/10.1016/j.jtct.2023.03.014
,2023, 'Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance', British Journal of Haematology, 201, pp. 865 - 873, http://dx.doi.org/10.1111/bjh.18704
,2023, 'The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance', British Journal of Haematology, 201, pp. 887 - 896, http://dx.doi.org/10.1111/bjh.18727
,